Tamarly Intelligence

Who Holds Aclaris Therapeutics, Inc. (ACRS)? 149 Institutional Holders, Q2 2026

Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 149 holders, $618 million in total.

Largest holders

The 100 largest by value. Change in shares against Q1 2026.

ManagerSharesValueChange
RA CAPITAL MANAGEMENT, L.P.12,723,026$67 million+87%13F
BML Capital Management, LLC11,975,000$63 million-16%13F
BlackRock, Inc.10,037,008$53 million+36%13F
Deep Track Capital, LP9,345,000$49 million+0%13F
Vivo Capital, LLC6,694,637$35 million+0%13F
VANGUARD CAPITAL MANAGEMENT LLC5,817,866$31 million+13%13F
Frazier Life Sciences Management, L.P.4,925,374$26 million+0%13F
Rock Springs Capital Management LP4,330,532$23 million-3%13F
ADAGE CAPITAL PARTNERS GP, L.L.C.4,071,000$22 million+5%13F
Decheng Capital LLC4,041,736$21 million+0%13F
STATE STREET CORP3,255,340$17 million+62%13F
GEODE CAPITAL MANAGEMENT, LLC3,190,058$17 million+32%13F
BRAIDWELL LP2,142,348$11 million+26%13F
Balyasny Asset Management L.P.2,023,470$11 million-40%13F
SILVERARC CAPITAL MANAGEMENT, LLC1,946,482$10 millionNew13F
Kalehua Capital Management LLC1,832,365$10 million+0%13F
CITADEL ADVISORS LLC1,762,081$9 million-22%13F
Jones Hill Capital LP1,759,492$9 millionNew13F
Palo Alto Investors LP1,613,430$9 million+0%13F
Woodline Partners LP1,611,054$9 million+8%13F
VANGUARD PORTFOLIO MANAGEMENT LLC1,465,735$8 million-11%13F
PANAGORA ASSET MANAGEMENT INC1,356,152$7 million+170%13F
Connor, Clark & Lunn Investment Management Ltd.1,209,886$6 million-15%13F
MPM BIOIMPACT LLC1,042,467$6 million+166%13F
DEUTSCHE BANK AG\1,040,955$6 million+4%13F
NORTHERN TRUST CORP998,763$5 million+37%13F
Aldebaran Capital, LLC936,731$5 million-1%13F
VANGUARD FIDUCIARY TRUST CO907,173$5 million+44%13F
RENAISSANCE TECHNOLOGIES LLC817,531$4 million+63%13F
Three Bridge Wealth Advisors, LLC714,823$4 million+0%13F
GOLDMAN SACHS GROUP INC609,158$3 million+3%13F
MILLENNIUM MANAGEMENT LLC523,895$3 million-31%13F
DIMENSIONAL FUND ADVISORS LP513,840$3 million+0%13F
JPMORGAN CHASE & CO468,964$2 million-4%13F
Aisling Capital Management LP434,455$2 million+0%13F
ORBIMED ADVISORS LLC421,500$2 millionNew13F
D. E. Shaw & Co., Inc.414,499$2 million-54%13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP412,549$2 million+9%13F
Tetragon Partners GP Ltd400,000$2 millionNew13F
Russell Investments Group, Ltd.365,055$2 million+18%13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC346,058$2 million+33%13F
FMR LLC313,850$2 million+78%13F
Bank of New York Mellon Corp282,599$1 million+37%13F
Nuveen, LLC278,404$1 million+136%13F
RAYMOND JAMES FINANCIAL INC275,611$1 million+3%13F
WELLINGTON MANAGEMENT GROUP LLP267,498$1 million+4%13F
SUPERSTRING CAPITAL MANAGEMENT LP257,675$1 million-30%13F
UBS Group AG257,001$1 million+24%13F
Invesco Ltd.243,028$1 million+13%13F
HighTower Advisors, LLC217,524$1 million-29%13F
Creative Planning206,647$1 million+36%13F
Logos Global Management LP200,000$1 million-60%13F
Verdad Advisers, LP175,272$927,189-11%13F
Informed Momentum Co LLC171,327$906,320-4%13F
Assenagon Asset Management S.A.154,554$817,591-13%13F
Atom Investors LP148,855$787,443New13F
RHUMBLINE ADVISERS143,216$757,603+90%13F
ALPS ADVISORS INC141,749$749,852+44%13F
SEI INVESTMENTS CO138,778$734,136-36%13F
MORGAN STANLEY134,117$709,477-95%13F
TWO SIGMA INVESTMENTS, LP133,068$703,930-66%13F
Vanguard Global Advisers, LLC129,056$682,706+88%13F
Hudson Bay Capital Management LP120,000$634,800+613%13F
CenterBook Partners LP118,228$625,426+78%13F
CITIGROUP INC117,786$623,088+1405%13F
BANK OF AMERICA CORP /DE/110,412$584,080+39%13F
WELLS FARGO & COMPANY/MN108,648$574,748+200%13F
Verition Fund Management LLC98,000$518,420New13F
STRS OHIO81,400$430,606+409%13F
Voleon Capital Management LP77,168$408,219New13F
Susquehanna Portfolio Strategies, LLC76,270$403,468+92%13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC75,019$396,851-77%13F
BARCLAYS PLC73,010$386,223+239%13F
MetLife Investment Management, LLC69,699$368,708+59%13F
AQR CAPITAL MANAGEMENT LLC60,259$318,771-17%13F
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.54,578$288,718+25%13F
MANGROVE PARTNERS IM, LLC50,291$266,039New13F
DIVERSIFIED TRUST CO45,523$240,816+55%13F
ALLIANCEBERNSTEIN L.P.57,000$213,750+275%13F
Police & Firemen's Retirement System of New Jersey38,826$205,390+97%13F
BNP PARIBAS FINANCIAL MARKETS35,524$187,922+66%13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE32,406$171,428+28%13F
PROFUND ADVISORS LLC30,486$161,271New13F
State of Wyoming27,439$145,152New13F
NEW YORK STATE COMMON RETIREMENT FUND27,300$144,417+0%13F
INTECH INVESTMENT MANAGEMENT LLC24,668$130,494+29%13F
VOYA INVESTMENT MANAGEMENT LLC23,104$122,220+42%13F
China Universal Asset Management Co., Ltd.22,228$117,586+4%13F
Rafferty Asset Management, LLC21,997$116,364New13F
PRUDENTIAL FINANCIAL INC20,270$107,228+51%13F
ProShare Advisors LLC20,095$106,302+7%13F
Walleye Capital LLC19,576$103,557New13F
NEUBERGER BERMAN GROUP LLC19,367$102,451-12%13F
Vontobel Holding Ltd.18,000$95,220-28%13F
CRA Financial Services, LLC17,782$94,067+0%13F
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management16,072$85,021New13F
Vanguard Personalized Indexing Management, LLC15,691$83,005-11%13F
Dynamic Technology Lab Private Ltd13,521$72,000New13F
VICTORY CAPITAL MANAGEMENT INC12,718$67,278+8%13F
TWO SIGMA SECURITIES, LLC12,671$67,030-44%13F

Questions and answers

How many institutions hold Aclaris Therapeutics, Inc.?
149 managers reported Aclaris Therapeutics, Inc. on Form 13F for the quarter ended 30 June 2026, against 136 the quarter before.
Who is the largest institutional holder of Aclaris Therapeutics, Inc.?
RA CAPITAL MANAGEMENT, L.P., with 12,723,026 shares worth $67 million on its 13F for Q2 2026.
How many institutions bought or sold out of Aclaris Therapeutics, Inc. in Q2 2026?
28 managers reported a new position and 15 reported none after holding it the quarter before.
See every holder, the full history and an alert when the next 13F filings land; the 7-day trial opens everything.Start the free trial

Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Aclaris Therapeutics, Inc., Q2 2026", https://app.tamarly.ai/holders/aclaris-therapeutics, built from SEC EDGAR.

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.